iLND provides a biologically grounded and anatomically precise strategy for regional management of vulvar carcinoma. By targeting high-risk nodal regions only, it enables therapeutic de-escalation while improving survival without reliance on radiotherapy or nuclear medicine. This benefit is relevant across healthcare systems and furthermore makes iLND suitable for low-resource settings.
Höckel et al. (Mon,) studied this question.